Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01303354 · ClinicalTrials.gov registry record · NA

Lumbar Transforaminal Epidural Dexamethasone

A NA study of Radicular; Neuropathic, Lumbar, Lumbosacral, sponsored by Ahadian, Farshad M., M.D..

Completed
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT01303354 is a NA study of Radicular; Neuropathic, Lumbar, Lumbosacral that has completed, run by Ahadian, Farshad M., M.D.. The registered enrollment target is 100 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01303354, a NA study of Radicular; Neuropathic, Lumbar, Lumbosacral, has completed, sponsored by Ahadian, Farshad M., M.D..

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

The aim of this study is to assess the effectiveness and safety of dexamethasone for transforaminal epidural steroid injection. A secondary aim of this study is to obtain data on the lowest most effective dose of dexamethasone for this treatment and the effective duration of effect.

Interventions

  • PROCEDURE Lumbar Transforaminal Epidural Steroid Injection

Study Locations (2)

California

  • University of California, San Diego - Center for Pain Medicine - La Jolla
  • San Diego VA Healthcare System - La Jolla

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2008-04
Est. Completion 2010-06
Phase NA

Sponsor

Ahadian, Farshad M., M.D.

1 total trials

What the Registry Record Tells You About NCT01303354

The ClinicalTrials.gov registry entry for NCT01303354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ahadian, Farshad M., M.D., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Radicular; Neuropathic, Lumbar, Lumbosacral appearing as the primary indexed condition, and to 1 intervention - of which Lumbar Transforaminal Epidural Steroid Injection is the first listed.

NCT01303354 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01303354 about?

NCT01303354 is a clinical study titled "Lumbar Transforaminal Epidural Dexamethasone". The aim of this study is to assess the effectiveness and safety of dexamethasone for transforaminal epidural steroid injection. A secondary aim of this study is to obtain data on the lowest most effective dose of dexamethasone for this treatment and the effective duration of effect.

What is the current status of trial NCT01303354?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2008-04. Estimated completion is 2010-06.

What conditions does trial NCT01303354 study?

This clinical trial studies the following conditions: Radicular; Neuropathic, Lumbar, Lumbosacral.

What interventions are being tested in trial NCT01303354?

The interventions under investigation include: Lumbar Transforaminal Epidural Steroid Injection (PROCEDURE).

Who is sponsoring clinical trial NCT01303354?

This trial is sponsored by Ahadian, Farshad M., M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01303354 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.